Your $6.1B research base is the credibility moat invisible on the wrist
A century of evidence anchors your cardiovascular authority. The $6.1B cumulative research investment is the largest credibility asset in the 19-brand cohort the dashboard tracks. It also lives nowhere on the surfaces where the 2050-burden cohort builds its body-vocabulary daily — the Apple Watch hypertension flag, the Oura Cycle Insights stack, the Function Health twice-yearly lab panel, the Levels CGM editorial. You own the science the consumer-health products are quietly substantiating. Differentiation at 53 against a cohort ceiling of 88 is the rank-level consequence of that surface absence.
stack-rank/impact-digest.md:L52-L58, v06 brief index.html:L763